A revolutionary nanoparticle approach from MIT researchers is overcoming immunotherapy resistance in ovarian cancer. By precisely delivering immune-stimulating molecules directly to tumors, the treatment achieved remarkable 80% cure rates while avoiding the dangerous side effects that have limited s
Groundbreaking research has uncovered that breastfeeding creates a lasting immune defense system in breast tissue that can protect against cancer for decades. Scientists identified specialized T-cells that remain active for over 30 years after pregnancy, providing enhanced protection against aggressive breast cancer forms.
New research has identified that breastfeeding provides women with long-lasting immune protection against breast cancer through specialized cells that remain active in breast tissue for more than 30 years, according to reports published in Nature. The study reveals that pregnancy and breastfeeding leave behind protective immune cells that continuously defend against cancer development, particularly targeting aggressive forms like triple-negative breast cancer.
